Science 37 accelerates clinical research by making it simple for patients to participate from the comfort of their own home. The company listed publicly [NASDAQ: SNCE] in 2021.

Science 37 is transforming the clinical research process by shifting the center for research from traditional academic sites to the patient’s home and local healthcare system. The platform is the industry’s first and only comprehensive, integrated platform purpose-built to support the systems, workflows, and processes of virtual trials.
-
Industry
-
Milestones
- Lux investment: 2015
- Publicly listed: 2021
-
Founders
- Noah Craft
- Belinda Tan
LUX Partners
-
Latest Tweets